Best Stocks: Biotech Still Holding Top Spots

By
A A A
Share |

At StateoftheMarkets.com, we focus our attention on the top-rated stocks of the market for a few simple reasons. The top stocks have the best earnings strength. The top stocks have strong fundamentals. The top stocks are also in the top-ranked industry groups. So from our perspective, the top stocks put the odds in your favor before you ever enter a buy order. So, why would anyone invest/trade in anything else?

Listed below are five companies that made our "10.0 Stocks Report" this week.

"10.0 Stocks" for the Week of April 22, 2013:

Company: Arena Pharmaceuticals ( ARNA )
Sector: Health Care
Industry: Biotech
Stock Rating: 10.0
Current Rating: Buy
Trading Stop: Close Below $7.79

Arena Pharmaceuticals Chart

Company: Pharmacyclics Inc ( PCYC )
Sector: Health Care
Industry: Biotech
Stock Rating: 10.0
Current Rating: Strong Buy
Trading Stop: Close Below $72.49

 Pharmacyclics Inc Chart

Company: Isis Pharmaceuticals ( ISIS )
Sector: Health Care
Industry: Biotech
Stock Rating: 10.0
Current Rating: Hold
Trading Stop: Close Below $18.19

Isis Pharmaceuticals Chart

Company: Onxx Pharmaceuticals ( ONXX )
Sector: Health Care
Industry: Biotech
Stock Rating: 10.0
Current Rating: Accumulate
Trading Stop: Close Below $91.89

Onxx Pharmaceuticals

Company: Alnylam Pharmaceuticals Inc ( ALNY )
Sector: Health Care
Industry: Biotech
Stock Rating: 10.0
Current Rating: Strong Buy
Trading Stop: Close Below $21.49

Alynlam Pharma chart

The StateoftheMarkets "Top Stock" Rating:
The TopStock Rating indicates the combined score of our proprietary Earning Strength and Company Performance models. The rating scale is 0 - 10 with 10 being the highest.

Current Rating:
The Current Rating is designed to let readers know what we would do now if we did NOT currently hold the position.

Strong Buy: Our favorite position. We would be willing to buy a full position at current levels.

Buy: We would be willing to buy at current levels.

Accumulate: We would be willing to take a "starter position" (25% - 33% of the full position) at current levels. However, we would not want to buy a full position at the current time and we would look to add to our "starter position" on weakness.

Hold: We prefer to hold our position at the current levels, but we would not be buyers at this time.

Sell: We are not happy with this position and are looking for an exit point.


This story by Dave Moenning originally appeared on StateOfTheMarkets.com .

Below, find some more great content from David Moenning and StateoftheMarkets.com:

Will It Be Enough This Time?

Are The Charts Telling The Real 'Story'?

Lost Money Lost on Gold? Try $560 Billion

Follow on Twitter: @StateDave



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Stocks

Referenced Stocks: ALNY , ARNA , ISIS , ONXX , PCYC

Minyanville

Minyanville

More from Minyanville:

Related Videos

Stocks

Referenced

Most Active by Volume

89,970,926
  • $16.15 ▲ 0.12%
77,131,582
  • $58.94 ▼ 1.31%
67,336,935
  • $26.56 ▲ 1.68%
48,814,124
  • $86.20 ▲ 0.02%
47,526,126
  • $23.21 ▲ 0.78%
44,660,424
  • $23.91 ▲ 6.36%
38,799,699
  • $4.289 ▲ 4.36%
36,199,890
  • $40.01 ▼ 0.97%
As of 4/17/2014, 04:07 PM